Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Amway Malaysia Holdings Bhd's average EBITDA Per Share Growth Rate was -20.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -14.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 8.60% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 5.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Amway Malaysia Holdings Bhd was 32.30% per year. The lowest was -21.90% per year. And the median was 0.30% per year.
Amway Malaysia Holdings Bhd (XKLS:6351) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Amway Malaysia Holdings Bhd 3-Year EBITDA Growth Rate Related Terms
XKLS:6351 vs CASY, WSM, ULTA: 3-Year EBITDA Growth Rate Comparison
For the Specialty Retail subindustry, Amway Malaysia Holdings Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amway Malaysia Holdings Bhd 3-Year EBITDA Growth Rate vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Amway Malaysia Holdings Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Amway Malaysia Holdings Bhd's 3-Year EBITDA Growth Rate falls into.
Amway Malaysia Holdings Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -14.40% mean?
Amway Malaysia Holdings Bhd (XKLS:6351) has a 3-Year EBITDA Growth Rate of -14.40% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Amway Malaysia Holdings Bhd and its competitors. According to the industry distribution chart, Amway Malaysia Holdings Bhd ranks #753 out of 916 companies in the Retail - Cyclical industry, placing it in the top 82.2%.
Is Amway Malaysia Holdings Bhd's 3-Year EBITDA Growth Rate too high?
Amway Malaysia Holdings Bhd's current 3-Year EBITDA Growth Rate is -14.40%. Based on the distribution chart, Amway Malaysia Holdings Bhd ranks #753 out of 916 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Amway Malaysia Holdings Bhd has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amway Malaysia Holdings Bhd's 3-Year EBITDA Growth Rate compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Amway Malaysia Holdings Bhd ranks #753 out of 916 companies for 3-Year EBITDA Growth Rate. This places Amway Malaysia Holdings Bhd in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 5.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Retail - Cyclical company?
The median 3-Year EBITDA Growth Rate among Retail - Cyclical companies is 5.35, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Amway Malaysia Holdings Bhd and its competitors. For the Retail - Cyclical industry, the median 3-Year EBITDA Growth Rate is 5.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amway Malaysia Holdings Bhd's current 3-Year EBITDA Growth Rate is -14.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amway Malaysia Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Amway Malaysia Holdings Bhd (XKLS:6351) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.93, compared to a current price of RM4.40 — trading 10.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -14.40%. Amway Malaysia Holdings Bhd's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Amway Malaysia Holdings Bhd (XKLS:6351), the current 3-Year EBITDA Growth Rate is -14.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amway Malaysia Holdings Bhd (XKLS:6351) Overvalued in 2026?
Based on GuruFocus' analysis, Amway Malaysia Holdings Bhd stock appears to be undervalued.
The current stock price of RM4.40 is trading 10.8% below its estimated GF Value™ of RM4.93.
GuruFocus considers Amway Malaysia Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:6351:
3-Year EBITDA Growth Rate: -14.40%
GF Value™: RM4.93 vs. price of RM4.40 (10.8% below fair value)
No single metric tells the full story. See the XKLS:6351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amway Malaysia Holdings Bhd is engaged in the distribution of consumer products under the Amway' trademark. The Group has only one business segment which is the distribution of consumer products principally under the Amway trademark. The company manufactures consumer products in the nutrition, beauty and home categories that are sold exclusively through Amway Business Owners. It has taken an initiative with Amway affiliates in Singapore, Thailand, Vietnam, Indonesia, Philippines, and Australia. The company also has an ARTISTRY SUPREME LX Regenerating Cream and Eye Cream under its skincare range and home categories that are sold exclusively through Amway Business Owners.
85GF Score
Get the complete analysis for XKLS:6351
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:6351 has been successfully added to your 
